UCB will ad­vance its an­ti-tau an­ti­body for Alzheimer’s dis­ease so­lo af­ter Roche and Genen­tech walked away from the as­set known as bepranemab.

Roche has returned the rights to UCB’s anti-tau antibody bepranemab, walking away from a $120 million bet on the Alzheimer’s disease drug candidate on the cusp of the release of phase 2a data.

The scene was set for the first game of the 2024 Pacific Championships on Friday night with a powerful Sipi Tau from the Tongan team. Veteran hooker Siliva Havili led the way for Tonga as the ...

This is an edition of the newsletter Pulling Weeds With Chris Black, in which the columnist weighs in on hot topics in culture. Sign up here to get it in your inbox every Thursday. When I was ...